Roger Zhu, MD (@RogerZhuMD) profile picture

Thoracic Surgeon @Northwellhealth SIUH. Father to two sons. MD Downstate. Gen Surg NYP-Q. Thoracic BWH. CT Montefiore.

Bronx, NY
Joined March 2018
Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)Photo by Roger Zhu, MD (@RogerZhuMD)
Roger Zhu, MD retweeted
The best set of slides on the potential impact of neoadjuvant chemo/immunotherapy ever by @nchudgar ? But putting our great surgeons out of business? Not yet pls- we love them on our multi-D team! Maybe we can find a new role for them when resections no longer needed? 😉 @BrendonStilesMD @NitinOhri3
1
26
63
6,554
📦🚨 PSA 10 Mega Gengar ex/PSA 10 Mega Charizard X ex Mystery Box Giveaway! 📦🚨 To enter: ✅ Repost and Like this Tweet ✅ Follow @PokeTCGAlerts and @DannypTCG Optional: Tag a friend and comment what you hope to get! This giveaway is for 1 FREE Mystery Box. Top chases include PSA 10 Mega Gengar ex and PSA 10 Mega Charizard X ex. Winner will be picked this Tuesday, June 9th! US only. Good luck! If you don't win you can buy a Mystery Box from Danny! Only 120 Mystery Boxes available. Boxes go live this Tuesday, June 9th at 5pm PST If you want to buy a Mystery box make sure to follow @DannypTCG and turn on notifications. Full details below 👇
413
1,576
5
1,767
127,215
Roger Zhu, MD retweeted
Proud to see this out from @ElsevierNews! Incredible contributions from many leaders in the field. Surgeons need to know systemic therapy! @BalazsHalmosMD @IsaOpitz @LindaMThoracic @GavittWoodard @DoctorJSpicer Jay Lee Masahiro Tsuboi @JonesDavid2013 @NitinOhri3 @maraantonoff
3
6
1
30
2,276
Roger Zhu, MD retweeted
Happy New Year Oncology Twitter! 🥳 Reminder: first round of travel award applications due in 10 days.
5
1
8
1,699
I would encourage all my colleagues confused by the 10 year follow up results from JCOG 0802 to watch this interview with Nasser Altorki @AltorkiNasser ctsnet.org/article/10-year-j… Here is a brief clip that I think summarizes the bottom line nicely
I feel compelled to circle back to this "bombshell" revelation posted on CTSNET. I don't intend to criticize my surgical colleagues, but I fail to understand the rationale for this webinar or how they reached the supposed "bombshell" conclusions... ctsnet.org/article/bombshell…
1
9
47
12,603
Roger Zhu, MD retweeted
teapaw.org/changjeesuk1/status/20… I had been trying to quietly disengage from this conversation (I promise!), but this pulled back in. Respectfully, I would suggest that not operating on biopsy proven NSCLC after SBRT should not be promoted as SOC. Several points important to make here:
100% agree. Just had a tough case (from a colleague)—post-SABR Bx showed ca without clear indication, and they rushed to surgery. Took a lot to convince them to hold off. MISSLE, RADSTER, ACT-II, and PSA were my go-to references as well.
3
2
1
20
7,813
The outcomes with non-surgical treatment for stage III NSCLC pioneered by a Spanish group reported in Nature Communications. @_ShankarSiva @fcounago @SalmaJabbour1 @NitinOhri3
1
9
1
28
7,008
I feel compelled to circle back to this "bombshell" revelation posted on CTSNET. I don't intend to criticize my surgical colleagues, but I fail to understand the rationale for this webinar or how they reached the supposed "bombshell" conclusions... ctsnet.org/article/bombshell…
3
13
1
31
18,364
"Bombshell" may be a stretch, but interesting to ponder long term results of JCOG0802. No meaningful differences between segmentectomy & lobectomy. Choice may ultimately come down to individual patient risk factors, tumor characteristics, & preferences. ctsnet.org/article/bombshell…
2
6
26
4,005
Outstanding opportunity to attend one of the best meetings in thoracic oncology!
Submit your abstract now for the #TexasLung26 Poster Competition! Open to trainees & junior faculty. Winners receive registration, travel, & hotel to present their poster at the meeting - Austin City Limits, April 9-11, 2026. See you @TLCconference! thetlcconference.com/poster-…
2
18
3,340
Lung metastases Excellent review👇 nature.com/articles/s41572-0…
2
102
2
407
33,592
This could be the next new quality metric having timely surgery for early stage lung cancer improves survival - @AATSHQ @AATSED @STS_CTsurgery @AmColSurgCancer @AmCollSurgeons @NLCRTnews @accpchest @GO2forLungCancr @atstoa @StanfordCAREs @KPDOR @KPMedSchool
A study by KPSOM faculty members, Drs. Lori Sakoda and Jeffrey Velotta, underscores the need for timely intervention in early-stage lung cancer. Read more: kpsom.link/40Nxh70
1
1
10
514
🚨 HOW TO DRIVE A LAPAROSCOPIC CAMERA 🚨 From DOMINATE SURGERY for medical students ➡️ app.behindtheknife.org/cours…
1
53
2
180
18,307
Roger Zhu, MD retweeted
In resectable gastric and gastroesophageal junction cancer, adding durvalumab to perioperative chemotherapy improved event-free survival and pathological complete response, with no major increase in high-grade adverse events. Full MATTERHORN phase 3 trial results and Research Summary: nej.md/437IXTF
55
4
135
22,852
Perhaps a new upcoming quality metric? Surgeries > 8 weeks from suspicious CT SCAN for early stage NSCLC had worse survival!!!! @AATSHQ @AATSED @STS_CTsurgery @AmCollSurgeons @KPDOR @KPMedSchool @UCSFSurgery
Free for 30 days: Time to surgery in early-stage non–small cell lung cancer: Defining the optimal diagnosis-to-resection interval to reduce mortality. Read in #JTCVS while it's open for all: doi.org/10.1016/j.jtcvs.2024… @JVelottaMD @KPDOR
5
12
1,192
Congrats on terrific presentation for Dr. Chaft @ChaftJamie on the 3-arm NEOADAURA trial showing much improved MPR/nodal downstaging by neoadj osi and chemo/osi vs chemo alone (which is pitiful on its own btw..) and excellent EFS for pts achieving MPR We will be scratching our heads a little as to how we will integrate this into practice but neoadj Ohhh-simertinib +/- chemo does have an appeal for N+/borderline resectable patients for sure! #ASCO25
2
1
10
2,144
Roger Zhu, MD retweeted
~13yrs of neoadjuvant adventure comes to positive conclusion (for now)! In @NEJM today & presented at #ASCO25 5 yr survival for pts w lung cancer that can be removed by surgery is better with just 3 doses of immunotherapy before the operation! nejm.org/doi/full/10.1056/NE… #LCSM 1/
11
103
10
426
44,224
Lots to think about! -If OS in CM816 shows similar improvement to KN671, should it be preferred regimen? -Will data dispel perceived need for adjuvant ICI after pCR? -Will neoadj TKIs move the needle? -Shouldn't we double down on increasing systemic therapy induced pCR? #ASCO25
I recommend checking out the CM816 OS, the outcomes by molecular profile from 77T, the first report of NeoADAURA findings and the complete data on arms 1, 2 and 4 of NeoCOAST2! Lots of great data that will inform practice and the next generation of phase 3 trials!
1
2
14
2,639
Retrospective study of neoadjuvant immunotherapy for 112 pts with stage III borderline resectable NSCLC @JAMAOnc. Included stage III with T4 and/or N2/3 NSCLC and 75% underwent surgery with 29% pCR, 42.2% MPR, mEFS 52.6m. Impressive to note that all N3 achieved ypN0.
1
29
3
100
9,668
This morning Dr. Goldstein received the @ISHLT 2025 Francis D. Pagani Endowed Mentorship Award for his tireless effort and commitment to mentoring the next generation of heart failure surgeons. 👏 #ISHLT2025
4
6
26
1,933